Skip to main contentSkip to navigation
Sirius Investors
Proteome Sciences plc

Proteome Sciences plc

PMSNF
OTCHealthcare

Proteome Sciences plc (PMSNF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Proteome Sciences plc's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
-2.40
Burn Risk
P/B Ratio
-0.77
Equity Deficit
Earnings Yield
-41.48%
Yield Gap

Profitability Health

2025
Return on Equity
32.12%
Strong
WeakModerateStrong
Operating Margin
-70.98%
Weak
WeakModerateStrong
Net Profit Margin
-81.50%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
-23.14%
Weak
WeakModerateStrong
Net Income Growth
10.12%
Moderate
WeakModerateStrong
EPS Growth
9.57%
Moderate
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
0.13
Weak
WeakModerateStrong
Quick Ratio
0.09
Weak
WeakModerateStrong
Asset Turnover
0.45x
Weak
WeakModerateStrong
Inventory Turnover
8.87x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-1.94%
Weak
WeakModerateStrong
EV / Free Cash Flow
-156.42x
Strong
WeakModerateStrong
Net Debt / EBITDA
-8.61x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.347
Strong
WeakModerateStrong
Return on Invested Capital
-34.27%
Weak
WeakModerateStrong
Cash Conversion Cycle
4.76 days
Moderate
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PMSNF.

View Financial Statements